Wells Fargo & Company MN Trims Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Wells Fargo & Company MN cut its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 11.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 474,834 shares of the exchange traded fund’s stock after selling 63,534 shares during the quarter. Wells Fargo & Company MN owned 0.62% of SPDR S&P Biotech ETF worth $42,398,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the business. EPG Wealth Management LLC grew its stake in SPDR S&P Biotech ETF by 152.7% in the 3rd quarter. EPG Wealth Management LLC now owns 460 shares of the exchange traded fund’s stock valued at $34,000 after acquiring an additional 278 shares during the period. Tennessee Valley Asset Management Partners acquired a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at $44,000. Wetzel Investment Advisors Inc. acquired a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at $45,000. Concourse Financial Group Securities Inc. grew its stake in SPDR S&P Biotech ETF by 21.2% in the 4th quarter. Concourse Financial Group Securities Inc. now owns 658 shares of the exchange traded fund’s stock valued at $59,000 after acquiring an additional 115 shares during the period. Finally, Life Planning Partners Inc acquired a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at $64,000.

SPDR S&P Biotech ETF Stock Performance

SPDR S&P Biotech ETF stock opened at $88.83 on Monday. The company’s fifty day moving average price is $89.66 and its 200 day moving average price is $87.88. The stock has a market capitalization of $6.77 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 1 year low of $63.80 and a 1 year high of $103.52.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.